This announcement is a separate document:
歐康維視生物-B：二零二二年中期報告
Ocumension Therapeutics-B: 2022 Interim Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.